Pages that link to "Q96190460"
Jump to navigation
Jump to search
The following pages link to Byron J. Hoogwerf (Q96190460):
Displaying 50 items.
- Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic review (Q27023364) (← links)
- Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes Association (Q28260334) (← links)
- Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes (Q28741419) (← links)
- Diabetes mellitus--overview (Q33263314) (← links)
- Safety and tolerability of acarbose in the treatment of type 1 and type 2 diabetes mellitus (Q33437382) (← links)
- The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study (Q33579765) (← links)
- Gender differences in utilization of effective cardiovascular secondary prevention: a Cleveland clinic prevention database study (Q33719272) (← links)
- The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes (Q33771752) (← links)
- Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial (Q33932781) (← links)
- Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial (Q34008233) (← links)
- Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database (Q34422144) (← links)
- Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications (Q34482329) (← links)
- Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association (Q34731503) (← links)
- Teambuilding and leadership training in an internal medicine residency training program (Q34732977) (← links)
- Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database study (Q34782893) (← links)
- A truly deadly quartet: obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia (Q35052793) (← links)
- Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure (Q35111553) (← links)
- Nutrition principles and recommendations in diabetes. (Q35615523) (← links)
- Association of dyslipidemia and effects of statins on nonmacrovascular diseases (Q35756752) (← links)
- Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis (Q35940436) (← links)
- Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease. (Q35968147) (← links)
- Elevated international normalized ratio in the ED: clinical course and physician adherence to the published recommendations (Q36020789) (← links)
- Exenatide and pramlintide: new glucose-lowering agents for treating diabetes mellitus (Q36481814) (← links)
- Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis (Q36907339) (← links)
- Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk (Q37193917) (← links)
- Managing type 2 diabetes: going beyond glycemic control (Q37205938) (← links)
- Does intensive therapy of type 2 diabetes help or harm? Seeking accord on ACCORD. (Q37304609) (← links)
- Evaluation of diabetic foot ulcer healing with hyperspectral imaging of oxyhemoglobin and deoxyhemoglobin (Q37400922) (← links)
- Cleveland Clinic cardiovascular intensive care unit insulin conversion protocol (Q37404433) (← links)
- Renin-angiotensin system blockade and cardiovascular and renal protection (Q37681742) (← links)
- Hypoglycemia in patients with type 2 diabetes using concomitant exenatide BID and long-acting insulin therapy (Q37926575) (← links)
- Risk Factors for Nocturnal Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database (Q38638256) (← links)
- Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes (Q38833207) (← links)
- Perspectives on Some Controversies in Cardiovascular Disease Risk Assessment in the Pharmaceutical Development of Glucose-Lowering Medications (Q39578110) (← links)
- Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study (Q39905736) (← links)
- Effects of exenatide on diabetes, obesity, cardiovascular risk factors, and hepatic biomarkers in patients with type 2 diabetes (Q42101166) (← links)
- High school body mass index and body mass index at entry to a cardiac disease risk prevention clinic and the association to all-cause mortality and coronary heart disease: a PreCIS database study (Q43157194) (← links)
- Blood glucose concentrations < or = 125 mg/dl and coronary heart disease risk (Q43897729) (← links)
- Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study. (Q43901638) (← links)
- Use of concomitant glucose-lowering therapies and associated treatment results observed in clinical trials of twice-daily exenatide (Q44284846) (← links)
- Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study (Q44321440) (← links)
- Hypothyroidism and Moderate Subclinical Hypothyroidism Are Associated with Increased All-Cause Mortality Independent of Coronary Heart Disease Risk Factors: A PreCIS Database Study (Q44464749) (← links)
- Relation of albumin/creatinine ratio to C-reactive protein and to the metabolic syndrome (Q44565528) (← links)
- Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study (Q44634431) (← links)
- The Heart Protection Study: high-risk patients benefit from statins, regardless of LDL-C level (Q44676726) (← links)
- Association of triglyceride-to-HDL cholesterol ratio with heart rate recovery (Q44816806) (← links)
- Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study (Q44845974) (← links)
- Ectopic adrenocorticotropic hormone syndrome caused by metastatic carcinoma of the prostate: therapeutic response to ketoconazole (Q44976687) (← links)
- Quality of life after coronary artery bypass graft: results from the POST CABG Trial (Q45012574) (← links)
- Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26. (Q45028947) (← links)